These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22361111)

  • 1. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
    Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
    J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
    Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
    PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
    Bu H; Schweiger MR; Manke T; Wunderlich A; Timmermann B; Kerick M; Pasqualini L; Shehu E; Fuchsberger C; Cato AC; Klocker H
    FEBS J; 2013 Mar; 280(5):1249-66. PubMed ID: 23294566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a synthetic cell panel to identify signalling components reprogrammed by the cell growth regulator anterior gradient-2.
    Gray TA; Alsamman K; Murray E; Sims AH; Hupp TR
    Mol Biosyst; 2014 Jun; 10(6):1409-25. PubMed ID: 24710632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.
    Chevet E; Fessart D; Delom F; Mulot A; Vojtesek B; Hrstka R; Murray E; Gray T; Hupp T
    Oncogene; 2013 May; 32(20):2499-509. PubMed ID: 22945652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer.
    Fessart D; Robert J; Hartog C; Chevet E; Delom F; Babin G
    J Exp Clin Cancer Res; 2021 Aug; 40(1):271. PubMed ID: 34452625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
    de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
    Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
    King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
    Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
    Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
    Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration.
    Park K; Chung YJ; So H; Kim K; Park J; Oh M; Jo M; Choi K; Lee EJ; Choi YL; Song SY; Bae DS; Kim BG; Lee JH
    Exp Mol Med; 2011 Feb; 43(2):91-100. PubMed ID: 21200134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of AGR2 and AGR3 in cancer: similar but not identical.
    Obacz J; Takacova M; Brychtova V; Dobes P; Pastorekova S; Vojtesek B; Hrstka R
    Eur J Cell Biol; 2015; 94(3-4):139-47. PubMed ID: 25666661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
    Salmans ML; Zhao F; Andersen B
    Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
    Lee WS; Park SY; Park YL; Joo YE
    In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGR2-AGR3 hetero-oligomeric complexes: Identification and characterization.
    Černocká H; Vonka P; Kasalová V; Sommerova L; Vandova V; Hrstka R; Ostatna V
    Bioelectrochemistry; 2021 Aug; 140():107808. PubMed ID: 33848875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling.
    Chi J; Zhang H; Hu J; Song Y; Li J; Wang L; Wang Z
    Cell Signal; 2020 Jan; 65():109419. PubMed ID: 31526829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
    Darb-Esfahani S; Fritzsche F; Kristiansen G; Weichert W; Sehouli J; Braicu I; Dietel M; Denkert C
    Virchows Arch; 2012 Aug; 461(2):109-16. PubMed ID: 22752467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
    Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B
    Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of human anterior gradient protein 3.
    Nguyen VD; Biterova E; Salin M; Wierenga RK; Ruddock LW
    Acta Crystallogr F Struct Biol Commun; 2018 Jul; 74(Pt 7):425-430. PubMed ID: 29969106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of genomic and transcriptomic alterations of
    Fessart D; Villamor I; Chevet E; Delom F; Robert J
    Open Biol; 2022 Jul; 12(7):220068. PubMed ID: 35857928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
    Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
    Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.